Haleon PLC Sponsored ADR (HLN) has released an update.
Haleon plc has announced Pfizer Inc.’s intention to sell approximately 630 million Haleon shares through a Global Offer, with Haleon concurrently planning a Share Buyback of approximately $400 million worth of shares from Pfizer. The Global Offer’s pricing will be determined by a bookbuilding process, with Pfizer retaining all proceeds, and is expected to decrease Pfizer’s stake in Haleon from 32% to around 24%. The offerings are part of Haleon’s strategic initiatives and are subject to customary closing conditions and regulatory approvals.
For further insights into HLN stock, check out TipRanks’ Stock Analysis page.
